Corrigendum to “SSP-27: 89Zr-immuno-PET of a novel bispecific amyloid β monoclonal antibody reveals improved and high specific brain uptake” [Nucl Med Biol (2020) Volumes 96–97, Supplement. S30-S31] (Nuclear Medicine and Biology (2021) 96–97(S) (S1–S114), (S0969805121X00042))

N. Stergiou, E. T. Wünsche, I. Mes, M. Schreurs, M. Verlaan, E. J. M. Kooijman, A. D. Windhorst, G. A. M. S. Dongen, L. Helboe, S. Vergo, S. Christensen, A. Asuni, A. Jensen, B. Bang-Andersen, D. J. Vugts, W. Beaino*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademic

Abstract

The authors regret <that the citation of Sehlin D. et al. Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's Disease, (Nature communication. 2016;7:10759) which described the delivery of radiolabelled bispecific antibodies into the brain via TfR1 mediated shuttle mechanism got missing in the final abstract>. The authors would like to apologise for any inconvenience caused.
Original languageEnglish
JournalNuclear Medicine and Biology
Early online date2021
DOIs
Publication statusE-pub ahead of print - 2021

Cite this